The clinical spectrum associated with myelin oligodendrocyte glycoprotein antibodies (anti-MOG-Ab) in Thai patients

Multiple Sclerosis

Volumn 22, Issue 7, 2016, Pages 964-968

  Siritho, Sasitorn ^a,b   Sato, Douglas K ^b,d   Kaneko, Kimihiko ^c   Fujihara, Kazuo ^c   Prayoonwiwat, Naraporn ^a  

^a MAHIDOL UNIVERSITY   (Thailand)

^b BUMRUNGRAD INTERNATIONAL HOSPITAL   (Thailand)

^c TOHOKU UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^d UNIVERSITY OF SÃO PAULO   (Brazil)

Author keywords

Biomarkers; epidemiology; neuromyelitis optica (NMO)

Indexed keywords

MYELIN OLIGODENDROCYTE GLYCOPROTEIN ANTIBODY; PROTEIN ANTIBODY; UNCLASSIFIED DRUG; ANTIBODY; AQUAPORIN 4 ANTIBODY; DIPYRIDAMOLE; METHYLPREDNISOLONE; PREDNISOLONE; AQP4 PROTEIN, HUMAN; AQUAPORIN 4; AUTOANTIBODY; BIOLOGICAL MARKER; MOG PROTEIN, HUMAN; MYELIN OLIGODENDROCYTE GLYCOPROTEIN;

ADULT; AGED; ANTIBODY SCREENING; ARTICLE; CENTRAL NERVOUS SYSTEM DISEASE; CLINICAL ARTICLE; CLINICAL FEATURE; FEMALE; HUMAN; INFLAMMATORY IDIOPATHIC DEMYELINATING CENTRAL NERVOUS SYSTEM DISORDER; MALE; MIDDLE AGED; OPTIC NEURITIS; PHENOTYPE; RELAPSE; THAI (PEOPLE); TREATMENT OUTCOME; VISION; ATAXIA; CEREBROSPINAL FLUID ANALYSIS; DEMYELINATING DISEASE; HEMIPARESIS; MAJOR CLINICAL STUDY; MEDICAL RECORD REVIEW; MYELITIS; MYELOOPTIC NEUROPATHY; NUCLEAR MAGNETIC RESONANCE IMAGING; PROGNOSIS; SJOEGREN SYNDROME; BLOOD; CASE REPORT; CONVALESCENCE; DIAGNOSTIC IMAGING; DIFFERENTIAL DIAGNOSIS; IMMUNOLOGY; PATHOPHYSIOLOGY; PREDICTIVE VALUE; RETROSPECTIVE STUDY; SEROLOGY; THAILAND; YOUNG ADULT;

AQUAPORIN 4; AUTOANTIBODIES; BIOMARKERS; DIAGNOSIS, DIFFERENTIAL; FEMALE; HUMANS; MAGNETIC RESONANCE IMAGING; MALE; MIDDLE AGED; MYELIN-OLIGODENDROCYTE GLYCOPROTEIN; NEUROMYELITIS OPTICA; OPTIC NEURITIS; PREDICTIVE VALUE OF TESTS; RECOVERY OF FUNCTION; RETROSPECTIVE STUDIES; SEROLOGIC TESTS; THAILAND; TREATMENT OUTCOME; VISION, OCULAR; YOUNG ADULT;

EID: 84973450041     PISSN: 13524585     EISSN: 14770970     Source Type: Journal    
DOI: 10.1177/1352458515614093     Document Type: Article

References (10)

1. Lennon VA, Wingerchuk DM, Kryzer TJ, et al. A serum autoantibody marker of neuromyelitis optica: distinction from multiple sclerosis. Lancet 2004; 364: 2106-2112
2. Fujihara K, Misu T, Nakashima I, et al. Neuromyelitis optica should be classified as an astrocytopathic disease rather than a demyelinating disease. Clin Exp Neuroimmunol 2012; 3: 58-73.
3. Wingerchuk DM, Lennon VA, Lucchinetti CF, et al. The spectrum of neuromyelitis optica. Lancet Neurol 2007; 6: 805-815.
4. Tanaka M, Tanaka K,. Anti-MOG antibodies in adult patients with demyelinating disorders of the central nervous system. J Neuroimmunol 2014; 270: 98-99.
5. Kitley J, Woodhall M, Waters P, et al. Myelinoligodendrocyte glycoprotein antibodies in adults with a neuromyelitis optica phenotype. Neurology 2012; 79: 1273-1277.
6. Sato DK, Callegaro D, Lana-Peixoto MA, et al. Distinction between MOG antibody-positive and AQP4 antibody-positive NMO spectrum disorders. Neurology 2014; 82: 474-481.
7. Kitley J, Waters P, Woodhall M, et al. Neuromyelitis optica spectrum disorders with aquaporin-4 and myelin-oligodendrocyte glycoprotein antibodies: A comparative study. JAMA Neurol 2014; 71: 276-283.
8. Amano H, Miyamoto N, Shimura H, et al. Influenza-associated MOG antibody-positive longitudinally extensive transverse myelitis: a case report. BMC Neurology 2014; 14: 224.
9. Reindl M, Di Pauli F, Rostásy K, et al. The spectrum of MOG autoantibody-associated demyelinating diseases. Nat Rev Neurol 2013; 9: 455-461.
10. Akaishi T, Sato DK, Nakashima I, et al. MRI and retinal abnormalities in isolated optic neuritis with myelin oligodendrocyte glycoprotein and aquaporin-4 antibodies: a comparative study. J Neurol Neurosurg Psychiatry Epub ahead of print 2015 6, pii: jnnp-2014-310206. doi: 10.1136/jnnp-2014-310206.